Osteocalcin Gene HindIII C/T Polymorphism Is a Biomarker for Prostate Cancer and Responsiveness to Hormone Therapy

By Wu H.-C.   Lin C.-C.   Chen W.-C.   Chen H.-Y.   Tsai F.-J.  

European Urology, Vol. 43, Iss. 2, 2003-02 ,pp. : 197-200

Elsevier

Access to resources Recommend Favorite

Vascular endothelial growth factor in prostate cancer

By Turner K.   Jones A.  

Urology, Vol. 56, Iss. 1, 2000-07 ,pp. : 183-183

Elsevier

Access to resources Recommend Favorite

Expression of vascular endothelial growth factor receptors in human prostate cancer

By Ferrer F.A.   Miller L.J.   Lindquist R.   Kowalczyk P.   Laudone V.P.   Albertsen P.C.   Kreutzer D.L.  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 567-572

Elsevier

Access to resources Recommend Favorite

Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer

By Baccala A.A.   Zhong H.   Clift S.M.   Nelson W.G.   Marshall F.F.   Passe T.J.   Gambill N.B.   Simons J.W.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Vitamin E and the Y4 Agonist BA-129 Decrease Prostate Cancer Growth and Production of Vascular Endothelial Growth Factor

By Yu A.   Somasundar P.   Balsubramaniam A.   Rose A.T.   Vona-Davis L.   McFadden D.W.  

Journal of Surgical Research, Vol. 105, Iss. 1, 2002-06 ,pp. : 65-68

Academic Press

Access to resources Recommend Favorite